Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis

被引：0
|
作者：
Neide Tomimura Costa
Tatiana Mayumi Veiga Iriyoda
Daniela Frizon Alfieri
Andréa Name Colado Simão
Isaias Dichi
机构：
[1] University of Londrina,Department of Rheumatology
[2] Pontifícia Universidade Católica (PUC),Department of Rheumatology
[3] University of Londrina,Research Laboratory of Applied Immunology
[4] University of Londrina,Department of Pathology, Clinical Analysis and Toxicology
[5] University of Londrina,Department of Internal Medicine
来源：
Inflammopharmacology | 2018年 / 26卷
关键词：
Disease-modifying antirheumatic drugs; Rheumatoid arthritis; Oxidative stress; Nitrosative stress;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1164
页数：13
相关论文
共 50 条
  • [31] Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients
    Joo, Young Bin
    Jung, Seung Min
    Park, Yune-Jung
    Kim, Ki-Jo
    Park, Kyung-Su
    [J]. JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (03): : 162 - 170
  • [32] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [33] SURVIVAL ANALYSIS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN SPANISH RHEUMATOID-ARTHRITIS PATIENTS
    DELAMATA, J
    BLANCO, FJ
    GOMEZREINO, JJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (11) : 881 - 885
  • [34] Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
    Lacaille, Diane
    Guh, Daphne P.
    Abrahamowicz, Michal
    Anis, Aslam H.
    Esdaile, John M.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (08): : 1074 - 1081
  • [35] Adherence to Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis A Narrative Review of the Literature
    Salt, Elizabeth
    Frazier, Susan K.
    [J]. ORTHOPAEDIC NURSING, 2010, 29 (04) : 260 - 275
  • [36] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [37] Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis
    Grijalva, Carlos G.
    Chung, Cecilia P.
    Arbogast, Patrick G.
    Stein, Charles M.
    Mitchel, Edward F., Jr.
    Griffin, Marie R.
    [J]. MEDICAL CARE, 2007, 45 (10) : S66 - S76
  • [38] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    [J]. JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [39] Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis
    Nandi, Pradip
    Kingsley, Gabrielle H.
    Scott, David L.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 251 - 256
  • [40] Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis
    van Riel, PLCM
    Haagsma, CJ
    Furst, DE
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (04): : 689 - 700
12345